Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation

REFERENCES

• Aprelikova, O., Y. Xiong, and E. T. Liu. 1995. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270:18195–18197.
   PubMed Web of Science ®Google Scholar
• Bagui, T. K., S. Mohapatra, E. Haura, and W. J. Pledger. 2003. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol. Cell. Biol. 23:7285–7290.
   PubMedGoogle Scholar
• Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:805–814.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, M. Strauss, and J. Bartek. 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027–1037.
   PubMedGoogle Scholar
• Berthet, C., K. D. Klarmann, M. B. Hilton, H. C. Suh, J. R. Keller, H. Kiyokawa, and P. Kaldis. 2006. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev. Cell 10:563–573.
   PubMed Web of Science ®Google Scholar
• Blain, S. W., E. Montalvo, and J. Massague. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272:25863–25872.
   PubMed Web of Science ®Google Scholar
• Bockstaele, L., K. Coulonval, H. Kooken, S. Paternot, and P. P. Roger. 2006. Regulation of CDK4. Cell Div. 1:25.
   PubMed Web of Science ®Google Scholar
• Bockstaele, L., H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval. 2006. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK “inhibitors.” Mol. Cell. Biol. 26:5070–5085.
   PubMed Web of Science ®Google Scholar
• Braden, W. A., A. K. McClendon, and E. S. Knudsen. 2008. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly. Oncogene 27:7083–7093.
   PubMedGoogle Scholar
• Brito-Babapulle, V., A. M. Gruszka-Westwood, G. Platt, C. L. Andersen, M. O. Elnenaei, E. Matutes, A. C. Wotherspoon, S. G. Weston-Smith, and D. Catovsky. 2002. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia. Haematologica 87:357–362.
   PubMedGoogle Scholar
• Cheng, M., V. Sexl, C. J. Sherr, and M. F. Roussel. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091–1096.
   PubMed Web of Science ®Google Scholar
• Corcoran, M. M., S. J. Mould, J. A. Orchard, R. E. Ibbotson, R. M. Chapman, A. P. Boright, C. Platt, L. C. Tsui, S. W. Scherer, and D. G. Oscier. 1999. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 18:6271–6277.
   PubMed Web of Science ®Google Scholar
• Costello, J. F., C. Plass, W. Arap, V. M. Chapman, W. A. Held, M. S. Berger, H. J. Su Huang, and W. K. Cavenee. 1997. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57:1250–1254.
   PubMed Web of Science ®Google Scholar
• Coulonval, K., L. Bockstaele, S. Paternot, J. E. Dumont, and P. P. Roger. 2003. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp. Cell Res. 291:135–149.
   PubMed Web of Science ®Google Scholar
• Darbon, J. M., A. Devault, S. Taviaux, D. Fesquet, A. M. Martinez, S. Galas, J. C. Cavadore, M. Doree, and J. M. Blanchard. 1994. Cloning, expression and subcellular localization of the human homolog of p40MO15 catalytic subunit of cdk-activating kinase. Oncogene 9:3127–3138.
   PubMedGoogle Scholar
• Day, P. J., A. Cleasby, I. J. Tickle, M. O'Reilly, J. E. Coyle, F. P. Holding, R. L. McMenamin, J. Yon, R. Chopra, C. Lengauer, and H. Jhoti. 2009. Crystal structure of human CDK4 in complex with a D-type cyclin. Proc. Natl. Acad. Sci. USA 106:4166–4170.
   PubMed Web of Science ®Google Scholar
• Depoortere, F., J. E. Dumont, and P. P. Roger. 1996. Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J. Cell Sci. 109:1759–1764.
   PubMedGoogle Scholar
• Depoortere, F., I. Pirson, J. Bartek, J. E. Dumont, and P. P. Roger. 2000. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Mol. Biol. Cell 11:1061–1076.
   PubMed Web of Science ®Google Scholar
• Depoortere, F., A. Van Keymeulen, J. Lukas, S. Costagliola, J. Bartkova, J. E. Dumont, J. Bartek, P. P. Roger, and S. Dremier. 1998. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J. Cell Biol. 140:1427–1439.
   PubMed Web of Science ®Google Scholar
• Diehl, J. A., and C. J. Sherr. 1997. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin- dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase. Mol. Cell. Biol. 17:7362–7374.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D- type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Farkas, T., K. Hansen, K. Holm, J. Lukas, and J. Bartek. 2002. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4. J. Biol. Chem. 277:26741–26752.
   PubMedGoogle Scholar
• Fisher, R. P. 2005. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J. Cell Sci. 118:5171–5180.
   PubMed Web of Science ®Google Scholar
• Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713–724.
   PubMed Web of Science ®Google Scholar
• Garrett, S., W. A. Barton, R. Knights, P. Jin, D. O. Morgan, and R. P. Fisher. 2001. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol. Cell. Biol. 21:88–99.
   PubMed Web of Science ®Google Scholar
• Gladden, A. B., and J. A. Diehl. 2003. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB. MCM7 binding. J. Biol. Chem. 278:9754–9760.
   PubMed Web of Science ®Google Scholar
• Gladden, A. B., and J. A. Diehl. 2005. Location, location, location: the role of cyclin D1 nuclear localization in cancer. J. Cell Biochem. 96:906–913.
   PubMed Web of Science ®Google Scholar
• Grimmler, M., Y. Wang, T. Mund, Z. Cilensek, E. M. Keidel, M. B. Waddell, H. Jakel, M. Kullmann, R. W. Kriwacki, and L. Hengst. 2007. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269–280.
   PubMed Web of Science ®Google Scholar
• Grossel, M. J., and P. W. Hinds. 2006. Beyond the cell cycle: a new role for Cdk6 in differentiation. J. Cell Biochem. 97:485–493.
   PubMedGoogle Scholar
• Harper, J. W., and S. J. Elledge. 1998. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev. 12:285–289.
   PubMed Web of Science ®Google Scholar
• James, M. K., A. Ray, D. Leznova, and S. W. Blain. 2008. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol. Cell. Biol. 28:498–510.
   PubMed Web of Science ®Google Scholar
• Kaldis, P. 1999. The cdk-activating kinase (CAK): from yeast to mammals. Cell. Mol. Life Sci. 55:284–296.
   PubMed Web of Science ®Google Scholar
• Kaldis, P., P. M. Ojala, L. Tong, T. P. Makela, and M. J. Solomon. 2001. CAK-independent activation of CDK6 by a viral cyclin. Mol. Biol. Cell 12:3987–3999.
   PubMedGoogle Scholar
• Kaldis, P., A. A. Russo, H. S. Chou, N. P. Pavletich, and M. J. Solomon. 1998. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol. Biol. Cell 9:2545–2560.
   PubMed Web of Science ®Google Scholar
• Kaldis, P., and M. J. Solomon. 2000. Analysis of CAK activities from human cells. Eur. J. Biochem. 267:4213–4221.
   PubMedGoogle Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487–496.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713–2721.
   PubMed Web of Science ®Google Scholar
• Kozar, K., M. A. Ciemerych, V. I. Rebel, H. Shigematsu, A. Zagozdzon, E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, R. T. Bronson, K. Akashi, and P. Sicinski. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477–491.
   PubMed Web of Science ®Google Scholar
• Larochelle, S., J. Batliner, M. J. Gamble, N. M. Barboza, B. C. Kraybill, J. D. Blethrow, K. M. Shokat, and R. P. Fisher. 2006. Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat. Struct. Mol. Biol. 13:55–62.
   PubMed Web of Science ®Google Scholar
• Larochelle, S., K. A. Merrick, M. E. Terret, L. Wohlbold, N. M. Barboza, C. Zhang, K. M. Shokat, P. V. Jallepalli, and R. P. Fisher. 2007. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 25:839–850.
   PubMed Web of Science ®Google Scholar
• Leng, X., M. Noble, P. D. Adams, J. Qin, and J. W. Harper. 2002. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol. Cell. Biol. 22:2242–2254.
   PubMed Web of Science ®Google Scholar
• Lujambio, A., S. Ropero, E. Ballestar, M. F. Fraga, C. Cerrato, F. Setien, S. Casado, A. Suarez-Gauthier, M. Sanchez-Cespedes, A. Git, I. Spiteri, P. P. Das, C. Caldas, E. Miska, and M. Esteller. 2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67:1424–1429.
   PubMed Web of Science ®Google Scholar
• Mahony, D., D. A. Parry, and E. Lees. 1998. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 16:603–611.
   PubMed Web of Science ®Google Scholar
• Malumbres, M., R. Sotillo, D. Santamaria, J. Galan, A. Cerezo, S. Ortega, P. Dubus, and M. Barbacid. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493–504.
   PubMed Web of Science ®Google Scholar
• Matsuoka, M., J. Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265–7275.
   PubMed Web of Science ®Google Scholar
• Matsuura, I., N. G. Denissova, G. Wang, D. He, J. Long, and F. Liu. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226–231.
   PubMed Web of Science ®Google Scholar
• Merrick, K. A., S. Larochelle, C. Zhang, J. J. Allen, K. M. Shokat, and R. P. Fisher. 2008. Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells. Mol. Cell 32:662–672.
   PubMed Web of Science ®Google Scholar
• Miliani de Marval, P. L., E. Macias, R. Rounbehler, P. Sicinski, H. Kiyokawa, D. G. Johnson, C. J. Conti, and M. L. Rodriguez-Puebla. 2004. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol. Cell. Biol. 24:7538–7547.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 2001. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10:699–703.
   PubMed Web of Science ®Google Scholar
• Obaya, A. J., I. Kotenko, M. D. Cole, and J. M. Sedivy. 2002. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. J. Biol. Chem. 277:31263–31269.
   PubMed Web of Science ®Google Scholar
• Ortega, S., M. Malumbres, and M. Barbacid. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 1602:73–87.
   PubMed Web of Science ®Google Scholar
• Paternot, S., K. Coulonval, J. E. Dumont, and P. P. Roger. 2003. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells. J. Biol. Chem. 278:26533–26540.
   PubMed Web of Science ®Google Scholar
• Paternot, S., J. E. Dumont, and P. P. Roger. 2006. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations of human thyrocytes by growth factors and TSH. Mol. Endocrinol. 20:3279–3292.
   PubMedGoogle Scholar
• Paternot, S., and P. P. Roger. 2009. Combined inhibition of MEK and mTOR abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation. Cancer Res. 69:4577–4581.
   PubMed Web of Science ®Google Scholar
• Ray, A., M. K. James, S. Larochelle, R. P. Fisher, and S. W. Blain. 2009. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Mol. Cell. Biol. 29:986–999.
   PubMed Web of Science ®Google Scholar
• Rocha, A. S., S. Paternot, K. Coulonval, J. E. Dumont, P. Soares, and P. P. Roger. 2008. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Mol. Biol. Cell 19:4814–4825.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Puebla, M. L., P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti. 2002. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. Am. J. Pathol. 161:405–411.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187–190.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and F. McCormick. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103–112.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Sotillo, R., P. Dubus, J. Martin, E. de la Cueva, S. Ortega, M. Malumbres, and M. Barbacid. 2001. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:6637–6647.
   PubMed Web of Science ®Google Scholar
• Takaki, T., A. Echalier, N. R. Brown, T. Hunt, J. A. Endicott, and M. E. Noble. 2009. The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. USA 106:4171–4176.
   PubMed Web of Science ®Google Scholar
• Tassan, J. P., S. J. Schultz, J. Bartek, and E. A. Nigg. 1994. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127:467–478.
   PubMed Web of Science ®Google Scholar
• Tetsu, O., and F. McCormick. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 3:233–245.
   PubMed Web of Science ®Google Scholar
• Tsakraklides, V., and M. J. Solomon. 2002. Comparison of Cak1p-like cyclin-dependent kinase-activating kinases. J. Biol. Chem. 277:33482–33489.
   PubMedGoogle Scholar
• Umeda, M., A. Shimotohno, and M. Yamaguchi. 2005. Control of cell division and transcription by cyclin-dependent kinase-activating kinases in plants. Plant Cell Physiol. 46:1437–1442.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Wohlbold, L., S. Larochelle, J. C. Liao, G. Livshits, J. Singer, K. M. Shokat, and R. P. Fisher. 2006. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity. Cell Cycle 5:546–554.
   PubMed Web of Science ®Google Scholar